|
DSM IV
Depression
Diagnosis
Criteria
Major
Depressive Episode
A. Five (or more) of the following symptoms have
been present during the same 2-week period and
represent a change from previous functioning; at
least one of the symptoms is either (1)
depressed mood or (2) loss of interest or
pleasure.
Note: Do note include symptoms that are
clearly due to a general medical condition, or
mood-incongruent delusions or hallucinations.
-
(1) depressed
mood most of the day, nearly every day, as indicated by either
subjective report (e.g., feels sad or empty) or observation made
by others (e.g., appears tearful). Note: In children and
adolescents, can be irritable mood.
-
(2) markedly
diminished interest or pleasure in all, or almost all,
activities most of the day, nearly every day (as indicated by
either subjective account or observation made by others
-
(3) significant
weight loss when not dieting or weight gain (eg., a change of
more than 5% of body weight in a month), or decrease or increase
in appetite nearly every day. Note: In children, consider
failure to make expected weight gains.
-
(4) insomnia or
hypersomnia nearly every day
-
(5) psychomotor
agitation or retardation nearly every day (observable by others,
not merely subjective feelings of restlessness or being slowed
down)
-
(6) fatigue or
loss of energy nearly every day
-
(7) feelings of
worthlessness or excessive or inappropriate guilt (which may be
delusional) nearly every day (not merely self-reproach or guilt
about being sick)
-
(8) diminished
ability to think or concentrate, or indecisiveness, nearly every
day (either by subjective account or as observed by others)
-
(9) recurrent
thoughts of death (not just fear of dying), recurrent suicidal
ideation without a specific plan, or a suicide attempt or a
specific plan for committing suicide
B. The symptoms
do not meet criteria for a Mixed Episode C. The symptoms
cause clinically significant distress or impairment in social,
occupational, or other important areas of functioning. D. The symptoms
are not due to the direct physiological effects of a substance
(e.g., a drug of abuse, a medication) or a general medical
condition (e.g., hypothyroidism). E. The symptoms
are not better accounted for by Bereavement, i.e., after the
loss of a loved one, the symptoms persist for longer than 2
months or are characterized by marked functional impairment,
morbid preoccupation with worthlessness, suicidal ideation,
psychotic symptoms, or psychomotor retardation.
Depression Diagnosis
Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa,
and cysteine to treat medical
patients in order to get these
results. Proper
use of these simple ingredients in
medical treatment is not simple.
From time to time a patient will
say, "Why do I want to take that, I
can go to a health food store and
buy it?" People off the street
buying in a health food store is
like going to an art store and
buying a bunch of oil paints then
going home and expecting to paint
like a mater artist even though
there was no previous painting
experience. These nutrients have
tremendous potential due to their
chemical properties. This potential
is only fully realized in the hands
of the trained professional using
neurotransmitter testing. Treatment
is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control.
The Peer Reviewed Research
of NeuroResearch Clinics
The neurotransmitter treatment research findings of NeuroResearch Clinics
have not been ignored. The University of
Minnesota Medical School is writing a series of
papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid
Kohlstadt, MD of Johns Hopkins in her new
medical text book released February 7, 2009
included a chapter on depression written by
Marty L. Hinz, MD President Clinical
Research NeuroResearch Clinics outlining in
depth the proper use of amino acids and
neurotransmitter testing in treatment of
depression.
|
